Shenzhen Hepalink Pharma News and Activities

Shenzhen Hepalink Pharma is a company listed under the stock ticker 002399 (CN).

Shenzhen Hepalink Pharma has a direct presence in 2 countries.

They are in:

• Pharmaceuticals50%
• Biotechnology50%

View the org chart displaying its 23 main executives

Most searched biographies at Shenzhen Hepalink Pharma

• Yu Shan, Executive Director, General Manager and Group Vice Presid...
• Li Li, Chairman of the Board
• Xi Gao, Senior Vice President of Global Supply Chain

Create your alert
to follow the executive moves at Shenzhen Hepalink Pharma.

Shenzhen Hepalink Pharma has 1,914 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Zymeworks has announced the acquisition of Theravance Biopharma  (posted on June 29 2026).
• Aurobindo has announced the acquisition of Lannett  (posted on June 26 2026).
• Merck has announced the acquisition of Bio-Techne  (posted on June 25 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Richard Saynor - Chief Executive Officer at Sandoz

Learn more about the Pharmaceuticals industry

Press releases by Shenzhen Hepalink Pharma

Social media about Shenzhen Hepalink Pharma

• Shenzhen Hepalink Pharma on Wikipedia, Google News & Yahoo Finance
• Shenzhen Hepalink Pharma on LinkedIn, X (Twitter) & YouTube